A possible influence of age on absorption and elimination of adalimumab in focal segmental glomerulosclerosis (FSGS)

Eur J Clin Pharmacol. 2016 Feb;72(2):253-5. doi: 10.1007/s00228-015-1973-1. Epub 2015 Oct 31.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab / administration & dosage
  • Adalimumab / blood
  • Adalimumab / pharmacology*
  • Adolescent
  • Adult
  • Age Factors
  • Child
  • Female
  • Glomerulosclerosis, Focal Segmental / metabolism*
  • Humans
  • Injections, Subcutaneous
  • Male
  • Models, Biological
  • Subcutaneous Absorption
  • Young Adult

Substances

  • Adalimumab